{
    "nctId": "NCT03195322",
    "briefTitle": "Pre-pectoral AlloDerm\u00ae to Reinforce Tissues in Tissue Expander Breast Reconstruction",
    "officialTitle": "The Use of Complete AlloDerm\u00ae Coverage in Two-stage Tissue Expansion and Implant Placement in the Subcutaneous (Pre-pectoral) Plane: a Prospective Pilot",
    "overallStatus": "COMPLETED",
    "conditions": "Postoperative Pain, Postoperative Nausea and Vomiting, Quality of Life, Breast Cancer, Breast Prosthesis; Pain",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "Evaluation of Postoperative Static Pain Score in patients receiving pre-pectoral Tissue Expander placement for Breast Reconstruction using Visual Analog Scale (VAS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Be women, aged 18-75 years.\n* Choose bilateral mastectomy (therapeutic or prophylactic) followed by immediate, bilateral pre-pectoral tissue expander breast reconstruction with complete AlloDerm\u00ae coverage.\n* Have no inflammatory breast cancers.\n* Be aware of the nature of her malignancy.\n* Understand the study purpose, requirements, and risks.\n* Be able and willing to give informed consent.\n\nExclusion Criteria:\n\n* Plan to undergo final reconstruction with autologous material.\n* Allergies to gentamicin, cefoxitin, lincomycin, vancomycin, or polymixin (antibiotics used in the pre-treatment of AlloDerm\u00ae).\n* Active connective tissue disease.\n* Current smokers.\n* History of, or plan to undergo irradiation of the breasts.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}